Walleye Capital’s Bristol-Myers Squibb BMY Stock Holding History

Walleye Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.73K	Sell	78 -25,141	-100%	-$1.47M	﹤0.01%	4200
2025 Q4	$1.36M	Sell	25,219 -168,056	-87%	-$8.08M	﹤0.01%	2184
2025 Q3	$8.72M	Buy	193,275 +158,980	+464%	+$7.42M	0.03%	606
2025 Q2	$1.59M	Buy	34,295 +27,889	+435%	+$1.37M	0.01%	1692
2025 Q1	$391K	Sell	6,406 -95,677	-94%	-$5.58M	﹤0.01%	2761
2024 Q4	$5.77M	Buy	102,083 +97,988	+2,393%	+$5.47M	0.01%	976
2024 Q3	$212K	Sell	4,095 -178,207	-98%	-$8.36M	﹤0.01%	3971
2024 Q2	$7.57M	Buy	+182,302	New	+$8.16M	0.01%	958
2023 Q4	–	Sell	-223,808	Closed	-$11.7M	–	4952
2023 Q3	$13M	Buy	+223,808	New	+$13.7M	0.03%	434
2022 Q2	–	Sell	-18,007	Closed	-$1.31M	–	2377
2022 Q1	$1.31M	Sell	18,007 -36,897	-67%	-$2.48M	0.04%	507
2021 Q4	$3.42M	Buy	+54,904	New	+$3.22M	0.11%	204
2020 Q4	–	Sell	-15,809	Closed	-$953K	–	947
2020 Q3	$953K	Buy	15,809 +8,241	+109%	+$496K	0.11%	252
2020 Q2	$445K	Buy	+7,568	New	+$453K	0.1%	247
2020 Q1	–	Sell	-4,170	Closed	-$268K	–	970
2019 Q4	$268K	Buy	4,170 +2,970	+248%	+$170K	0.02%	988
2019 Q3	$61K	Buy	1,200 +600	+100%	+$28.2K	﹤0.01%	1560
2019 Q2	$27K	Hold	600	–	–	﹤0.01%	1486
2019 Q1	$29K	Buy	+600	New	+$29.9K	﹤0.01%	1299

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Capital's BMY Position: Q1 2026 in Review

Walleye Capital reduced its Bristol-Myers Squibb (BMY) stake by 100% in Q1 2026, selling an estimated $1.47M and leaving 78 shares worth $4.73K. The position accounts for ﹤0.01% of the portfolio, ranked #4200.

Walleye Capital first reported a position in BMY in Q1 2019 and has held it in 17 quarters since. The position peaked at $13M in Q3 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Walleye Capital held 78 shares of Bristol-Myers Squibb worth $4.73K as of Q1 2026.
Walleye Capital sold 25,141 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.47M.
Bristol-Myers Squibb made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4200 holding.
Walleye Capital first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 17 quarters since.
Walleye Capital's Bristol-Myers Squibb position peaked at $13M in Q3 2023.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.